
Antibody engineering after generative AI: Solving the validation bottleneck
Stacey Willard, Vice President of Marketing and Product Management at Nuclera, explores the validation bottleneck for antibody engineering and why generative AI may be the answer to this challenge. Antibody engineering has developed a pronounced asymmetry. AI can now generate and rank antibody candidates at a pace that conventional experimental… Read More













